[1] |
SHEN Jiaqing, LIU Yi.
Mechanism of tyrosine kinase 2 inhibitors in treatment of plaque psoriasis and their progress in clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 323-330.
|
[2] |
WU Yi, FANG Fang, CHEN Ying, Fan Junwei.
Influence of donor and recipient CYP3A5 genotype on tacrolimus trough concentrations in the early stage after liver transplantation and its clinical significance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(6): 631-639.
|
[3] |
MIN Hang, GUO Mengran, YE Yue, XU Xiaoshuang, ZHEN Donghu.
Research progress of thyroid dysfunctions during treatment with immune-checkpoint inhibitors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 223-229.
|
[4] |
ZHU Zhengyi, NI Yinghua, GAO Peng, WANG Huijuan, HUANG Lingfei, HU Yan, ZHANG Liwen, YANG Jufei, FANG Luo.
Tocilizumab related adverse events: A cross-section analysis of FDA Adverse Event Reporting System
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(8): 895-902.
|
[5] |
YAN Lin, WANG Jingjing, HUANG Hua, YAO Qin, LI Qian, ZHANG Jun.
Application of immunosuppressive agents in pregnancy after organ transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1317-1320.
|
[6] |
WANG Yan, BU Wen-ting, LI Peng-fei, MA Ping, GAO Wen-jing, SUN Jian-zi.
Advancement of the drug monitoring methods of immunodepressants in human blood
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(7): 830-836.
|
[7] |
WANG Wei-Bo, LI Wen-Guang, LU Li, WU Yong-Jie, GAO Ming-Tang.
Comparison of change of body temperature in mice induced by intravenously and intramuscularly injection of different dosage of rhIFNα2a
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(12): 1432-1435.
|
[8] |
YU Tang-Hong, JIA Ru-Han, DING Guo-Hua, XIONG Yan, CHEN Jian.
Protective effects of mycophenolate mofetil on kidneys of type 2 diabetic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(10): 1119-1122.
|
[9] |
LU Yan-Xu, CHEN Min-Zhu, LU Jing-Tao.
Combined therapeutic effects of recombinant human IL-10 with soluble chicken type Ⅱ collagen on experimental arthritis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(4): 426-429.
|
[10] |
LU Yan-Xu, CHEN Min-Zhu.
Immune therapeutic effect of oral soluble chicken collagen type Ⅱon adjuvant arthritis in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(2): 180-183.
|
[11] |
CHEN Ken, LONG You-Ming, LAN Lei, ZHENG Jie-Shun, WANG Hui.
Activation of NF-κB and anti-inflammation mechanism of pyrrolidine dithiocarbamate in rats with acute colitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(2): 184-188.
|
[12] |
YU Ai-Rong, WU Xiao-Chun, LI Qing, XIN Hua-Wen, ZHONG Ming-Yuan, XIE Sen.
Gender difference of pharmacokinetics of oral cyclosporin A in renal transplanted recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(2): 220-222.
|
[13] |
WANG Yong, HU Jie-Gui, HU Xian-Wei.
Clinical evaluation of mycobacterium phlei combined with cisplatin in treatment of patients with malignant pleural effusion
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(1): 107-109.
|
[14] |
HU Guo-Hua.
Influence of tripterygium wilfordii on the children with nephrotic proteinuria
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(3): 336-338.
|
[15] |
WU Xiao-Chun, ZHONG Ming-Yuan, XIN Hua-Wen, LI Qing, YU Ai-Rong, ZHOU Qiu-Xiang.
Pharmacokinetics of cyclosporin A coadministrated with berberine in Chinese healthy volunteers1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(2): 136-138.
|